The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
Open accessAbstract
Objective: Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness of depot leuprolide acetate, a synthetic gonadotropin‐releasing hormone analog (GnRH‐a), for protection against POF during CYC therapy. Methods: Young women with severe SLE treated in a standardized protocol of monthly intravenous bolus CYC were offered treatment with GnRH‐a (depot leuprolide acetate; a 3.75‐mg monthly injection during the standard CYC regimen). Patients treated with GnRH‐a were compared with controls individually matched by age (±5 years) and by cumulative CYC dose (±5 gm). Reproductive status was determined after a minimum followup of 3 years after CYC therapy. The primary outcome was time to POF. Paired summary statistical analyses, Kaplan‐Meier survival estimates, and Cox regression analyses were performed to assess differences in outcome between groups. Results: POF developed in 1 of 20 women treated with GnRH‐a (5%) compared with 6 of 20 controls (30%) matched by age and cumulative CYC dose (matched odds ratio 0.09, P < 0.05). Kaplan‐Meier estimates demonstrated improved cumulative ovarian protection over time in the GnRH‐a–treated group (P = 0.04). Conclusion: Treatment with GnRH‐a during CYC therapy was associated with a significant reduction of POF in young women with severe SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
The Practice Committee of the American Society for Reproductive Medicine
Birmingham, A. (2006) · Cited by 1,925
Boumpas, D. T., Austin, H. A., Balow, J. E., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Steinberg, A. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92292-n · Cited by 823
Sequential Therapies for Proliferative Lupus Nephritis
Contreras, G., Pardo, V., Leclercq, B., Lenz, O., Tozman, E., O'Nan, P., & Roth, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031855 · Cited by 818
Boumpas, D. T., Austin, H. A., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00003 · Cited by 500
Prospective Study of the Determinants of Age at Menopause
Bromberger, J. T., Matthews, K. A., Kuller, L. H., Wing, R. R., Meilahn, E. N., & Plantinga, P. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009083 · Cited by 433
Cyclophosphamide-Induced Ovarian Failure
Warne, G. L., Fairley, K. F., Hobbs, J. B., & Martin, F. I. R. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311292892202 · Cited by 405
Failure to preserve fertility in patients with Hodgkin's disease
Waxman, J. H., Ahmed, R., Smith, D., Wrigley, P. F. M., Gregory, W., Shalet, S., Crowther, D., Rees, L. H., Besser, G. M., Malpas, J. S., et al. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254570 · Cited by 319
McCune, W. J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., & Fox, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806023182203 · Cited by 282
Self-citation
Cited by
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790
Self-citationBertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Groh, M., Pagnoux, C., Baldini, C., Bel, E., Bottero, P., Cottin, V., Dalhoff, K., Dunogué, B., Gross, W., Holle, J., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.022 · Cited by 476
Metadata
- Authors
- Somers, E. C., Marder, W., Christman, G. M., Ognenovski, V., & McCune, W. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-09
- Volume
- 52
- Issue
- 9
- Pages
- 2761-2767
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2019229100
- Cited by
- 269
- References
- 33
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. https://app.cochat.ai/papers/10.1002/art.21263
- The paper
- Somers, E. C., Marder, W., Christman, G. M., Ognenovski, V., & McCune, W. J. (2005). Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis & Rheumatism. https://doi.org/10.1002/art.21263
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.